This excerpt taken from the NFLX 10-K filed Mar 16, 2006.
In 2005, the Company capitalized $481 related to certain technology patents acquired. The capitalized patents are being amortized to Technology and Development in the Consolidated Statements of Income over the remaining useful life of the patents, the last of which expires in September 2015. The annual amortization expense of the patents that existed as of December 31, 2005 is expected to be approximately $47 for each of the five succeeding years.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(in thousands, except share, per share and percentages)